Skip to content

To study the effect of vruddhadaru (Argyriea speciosa Linn.)on anxiety

Randomized controlled clinical study to evaluate the efficacy of vruddhadaru churna in treatment of generalized anxiety disorder in geriatric age group. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080808
Enrollment
50
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Sponsors

Dr Pallavi Gajanan Chincholkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients suffering from symptoms of genralized anxiety disorder such as fatigue, mental confusion , worry, sleep disturbances, restlessness lower level of cognitive ad somatic distress, panic disorder, more dizziness and faintness

Exclusion criteria

Exclusion criteria: Serious illness such as cancer kidney disease and heart disease known case of mental retardation or having any other psychological disorders

Design outcomes

Secondary

MeasureTime frame
increase quality of life sound sleepTimepoint: 45 days

Primary

MeasureTime frame
reduction in symptoms of generalised anxiety disorderTimepoint: 45 days

Countries

India

Contacts

Public ContactDr Asmita Uday Jadhav

Tilak Ayurved Mahavidyalaya, Pune

asmita.niramaya@gmail.com9359772607

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026